Compound ID | 147
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Pseudomonas aeruginosa |
| Combined with other compounds: | Yes |
| Description: | A siderophore-monobactam conjugate |
| Institute where first reported: | Pfizer, USA |
| Year first mentioned: | 2015 |
| Development status: | Experimental |
| External links: | |
| Citations: |
|